Consolidated Statement Of Cash Flows

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7247022

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
3,213,975,000 JPY
12,618,613,000 JPY
9,508,394,000 JPY
2,111,978,000 JPY
Depreciation
6,843,170,000 JPY
6,341,193,000 JPY
Amortization of goodwill
711,521,000 JPY
1,214,257,000 JPY
Interest and dividend income
-623,522,000 JPY
-438,760,000 JPY
Interest expenses
452,290,000 JPY
457,801,000 JPY
Foreign exchange losses (gains)
-362,710,000 JPY
-143,268,000 JPY
Increase (decrease) in provision for bonuses
644,000 JPY
-100,880,000 JPY
Increase (decrease) in retirement benefit liability
47,812,000 JPY
-154,069,000 JPY
Share of loss (profit) of entities accounted for using equity method
276,717,000 JPY
76,855,000 JPY
Decrease (increase) in trade receivables
-4,800,944,000 JPY
-2,075,167,000 JPY
Subtotal
13,791,609,000 JPY
13,107,561,000 JPY
Income taxes paid
-1,001,049,000 JPY
-915,993,000 JPY
Decrease (increase) in inventories
-1,647,358,000 JPY
-863,940,000 JPY
Increase (decrease) in trade payables
567,039,000 JPY
1,052,362,000 JPY
Net cash provided by (used in) operating activities
12,922,046,000 JPY
12,183,609,000 JPY
Other, net
49,281,000 JPY
-74,411,000 JPY
Interest and dividends received
623,494,000 JPY
438,760,000 JPY
Interest paid
-492,007,000 JPY
-446,719,000 JPY
Cash flows from investing activities
Payments into time deposits
-125,000,000 JPY
-1,668,141,000 JPY
Proceeds from withdrawal of time deposits
1,787,659,000 JPY
125,000,000 JPY
Purchase of property, plant and equipment
-1,429,102,000 JPY
-2,900,688,000 JPY
Purchase of investment securities
JPY
-2,313,000 JPY
Net cash provided by (used in) investing activities
-1,050,885,000 JPY
-3,952,373,000 JPY
Proceeds from sale of investment securities
JPY
2,018,805,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-662,000 JPY
-824,000 JPY
Net increase (decrease) in short-term borrowings
-143,500,000 JPY
-560,176,000 JPY
Dividends paid
-1,976,755,000 JPY
-1,935,396,000 JPY
Proceeds from long-term borrowings
3,273,000,000 JPY
500,000,000 JPY
Repayments of long-term borrowings
-8,515,015,000 JPY
-5,778,110,000 JPY
Dividends paid to non-controlling interests
JPY
-2,308,000 JPY
Net cash provided by (used in) financing activities
-7,756,699,000 JPY
-8,124,090,000 JPY
Repayments of lease liabilities
-393,767,000 JPY
-348,090,000 JPY
Effect of exchange rate change on cash and cash equivalents
749,071,000 JPY
2,402,921,000 JPY
Net increase (decrease) in cash and cash equivalents
4,863,532,000 JPY
2,510,065,000 JPY
Cash and cash equivalents
23,467,676,000 JPY
18,604,144,000 JPY
16,094,078,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.